A citation-based method for searching scientific literature


List of co-cited articles
558 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
12



Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

Evolution of resistance during clonal expansion.
Yoh Iwasa, Martin A Nowak, Franziska Michor. Genetics 2006
145
9

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
689
9

Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
B Fisher, N Gunduz, J Coyle, C Rudock, E Saffer. Cancer Res 1989
317
8

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
8

Evolutionary dynamics of cancer in response to targeted combination therapy.
Ivana Bozic, Johannes G Reiter, Benjamin Allen, Tibor Antal, Krishnendu Chatterjee, Preya Shah, Yo Sup Moon, Amin Yaqubie, Nicole Kelly, Dung T Le,[...]. Elife 2013
373
8

Stochastic modeling of drug resistance in cancer.
Natalia Komarova. J Theor Biol 2006
67
11


Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
Caroline Lohrisch, Charles Paltiel, Karen Gelmon, Caroline Speers, Suzanne Taylor, Jeff Barnett, Ivo A Olivotto. J Clin Oncol 2006
257
7

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.
James J Biagi, Michael J Raphael, William J Mackillop, Weidong Kong, Will D King, Christopher M Booth. JAMA 2011
408
7

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Marc L Citron, Donald A Berry, Constance Cirrincione, Clifford Hudis, Eric P Winer, William J Gradishar, Nancy E Davidson, Silvana Martino, Robert Livingston, James N Ingle,[...]. J Clin Oncol 2003
7

Drug resistance in cancer: principles of emergence and prevention.
Natalia L Komarova, Dominik Wodarz. Proc Natl Acad Sci U S A 2005
242
7


Adaptive therapy.
Robert A Gatenby, Ariosto S Silva, Robert J Gillies, B Roy Frieden. Cancer Res 2009
440
7



The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
7

A view on drug resistance in cancer.
Neil Vasan, José Baselga, David M Hyman. Nature 2019
655
7

Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
M Colleoni, M Bonetti, A S Coates, M Castiglione-Gertsch, R D Gelber, K Price, C M Rudenstam, J Lindtner, J Collins, B Thürlimann,[...]. J Clin Oncol 2000
158
6

Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.
Gaetan Des Guetz, Patrick Nicolas, Gérard-Yves Perret, Jean-François Morere, Bernard Uzzan. Eur J Cancer 2010
151
6


Drug resistance and the solid tumor microenvironment.
Olivier Trédan, Carlos M Galmarini, Krupa Patel, Ian F Tannock. J Natl Cancer Inst 2007
6

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, C Robert Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. Obstet Gynecol 2006
326
6

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
6

Evolution of acquired resistance to anti-cancer therapy.
Jasmine Foo, Franziska Michor. J Theor Biol 2014
142
6

An elementary approach to modeling drug resistance in cancer.
Cristian Tomasetti, Doron Levy. Math Biosci Eng 2010
32
18

Drug penetration in solid tumours.
Andrew I Minchinton, Ian F Tannock. Nat Rev Cancer 2006
6


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
6

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Rajendra Badwe, Rohini Hawaldar, Nita Nair, Rucha Kaushik, Vani Parmar, Shabina Siddique, Ashwini Budrukkar, Indraneel Mittra, Sudeep Gupta. Lancet Oncol 2015
289
5

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.
Erika A Danna, Pratima Sinha, Mileka Gilbert, Virginia K Clements, Beth A Pulaski, Suzanne Ostrand-Rosenberg. Cancer Res 2004
238
5

Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
Jennifer Gnerlich, Donna B Jeffe, Anjali D Deshpande, Courtney Beers, Christina Zander, Julie A Margenthaler. Ann Surg Oncol 2007
203
5



Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Debora de Melo Gagliato, Ana M Gonzalez-Angulo, Xiudong Lei, Richard L Theriault, Sharon H Giordano, Vicente Valero, Gabriel N Hortobagyi, Mariana Chavez-Macgregor. J Clin Oncol 2014
171
5

Rationale for the use of alternating non-cross-resistant chemotherapy.
J H Goldie, A J Coldman, G A Gudauskas. Cancer Treat Rep 1982
615
5

Mechanisms of cancer drug resistance.
Michael M Gottesman. Annu Rev Med 2002
5

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.
Hiroshi Haeno, Mithat Gonen, Meghan B Davis, Joseph M Herman, Christine A Iacobuzio-Donahue, Franziska Michor. Cell 2012
280
5


New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
5

Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.
Mariana Chavez-MacGregor, Christina A Clarke, Daphne Y Lichtensztajn, Sharon H Giordano. JAMA Oncol 2016
195
5

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
230
5

Clonal evolution in cancer.
Mel Greaves, Carlo C Maley. Nature 2012
5

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
5

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
5

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi, Fumiaki Takahashi, Hirofumi Michimae, Eizo Kimura, Daisuke Aoki, Toshiko Jobo, Shoji Kodama, Fumitoshi Terauchi,[...]. Lancet Oncol 2013
300
5

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.
Juliann Chmielecki, Jasmine Foo, Geoffrey R Oxnard, Katherine Hutchinson, Kadoaki Ohashi, Romel Somwar, Lu Wang, Katherine R Amato, Maria Arcila, Martin L Sos,[...]. Sci Transl Med 2011
379
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.